The discovery of Helicobacter pylori, by Warren and Marshall in 1982, was preceded by nearly 100 years of inconspicuous publications relating to spiral bacteria, achlorhydria, gastritis, gastric urease, and antimicrobial therapy for ulcers. Japanese investigators, notably Kasai and Kobayashi, should be acknowledged for their pioneering work showing that spiral bacteria could infect many ani mals, could cause haemorrhagic erosions, and would be effectively cured with various antimicrobials.
It must have been very difficult for gastroentero logists and physicians to accept the proposal of two un known investigators, Marshall and Warren, who stated in 1983 that spiral bacteria in the human stomach were likely to be the cause of peptic ulcers.1 Not only did these two have no track record, but also they seemed to be supremely confident that their hypothesis was cor rect. This is where the relevance of the history of Heli cobacter pylori becomes evident. The key to Marshall and Warren's confidence was the historical literature on gastric bacteria, including the reports of Kasai and Kobayashi. In their review of the medical history of spiral bac teria, Marshall and Warren detected four clues to H. pylori. These were: 1. Spiral bacteria in the stomach. 2. Epidemic hypochlorhydria (the acute infection with H. pylori, usually seen in children). 3. Gastric urease (by which H. pylori releases ammonia and survives in the acid-secreting stomach). 4. Descriptions of antibiotic therapy for gastric diseases particularly peptic ulcer.
Spiral Gastric Bacteria
In 1892, the Italian anatomist Bizzozero described gram-negative spirochetes within parietal cells of the dog stomach. Bizzozero postulated that either these bacteria must have been acid tolerant, or, alternatively, they could turn off acid secretion. 2 We now know that both of these facts are true of H. pylori, as it exhibits a degree of acid tolerance, as well as being able to induce achlorhydria. Table 1 , they then used Arsaminol (the Japanese equivalent of Salvarsan-an arsenical) to eradicate the bacteria from mice stomachs. It is inter esting to note that they always used controls in their experiments, and that they documented that the drug was effective at 1:300 dilution (3mg/ml).
As shown in Table 2 , Kobayashi found that dogs, cats and monkeys all had the organism, but that other species-rabbits, mice, voles and guinea pigs-did not3 . These results have certainly been verified in modern studies. Many years passed before mice were success fully colonised by H. pylori.4 However, there is now a mouse model, although it is less than ideal since the mouse stomach is so different from the human stomach .
Lytic Actions of Saponin, Sodium Taurocholate and
Bile on the Spirochaete
In the days before antibiotic therapy, Kobayashi was interested in natural compounds that could inhibit the It now appears that, as far as could be done at the time, Kasai and Kobayashi fulfilled Koch's postulates for gastric spirochaetes and erosive gastritis. A rabbit adapted spirochaete strain could be shown to have no effect when spirochaetes alone were instilled into the stomach (Table 4 ). However, usually the infection would not establish, but in the presence of a rabies in fection, rabbit-adapted strains caused heavy colonisa tion. Following this, marked haemorrhagic changes were seen in the gastric mucosa. One can only speculate as to why rabies potentiated the spirochaetes' pathoge nicity. Probably gastric hypersecretion occurred as part of the sympathetic overdrive seen in CNS conditions and this favoured the growth of the bacteria in some way. One wonders whether Kobayashi was really aware of similar gastric lesions that occurred in humans. Of course he had no access to endoscopy, but it is surpris ing that he did not discuss human disease parallels in his paper.
In summary, Kasai and Kobayashi observed that the spiral organism lives in the fundic glands of the stom ach. It is present in cats, dogs, and monkeys, but not in rabbits, mice, guinea pigs or voles. It is soluble in sap onin and taurocholate and bile. It is susceptible to sal varsan in the stomach and parenterally.
It is easily transmitted to rats and mice, but not easily to rabbits or guinea pigs. After infection with the spirochaete, a rabbit infected with virus fixe of rabies would develop gastric haemorrhagic erosions. Quite clearly, Kobayashi considered the idea of an infectious agent causing stomach disease. He was also the first person to con sider treating gastric disease with arsenic as a specific antimicrobial. A second Japanese investigator appeared in the Helicobacter pylori story in 1967. Susumu Ito, a well -known anatomist from Boston, had illustrated a per fectly formed Helicobacter pylori organism within the canaliculus of a parietal cell ( Fig. 1 ).5 In fact, this or ganism was taken from Ito's own stomach. He swal lowed a biopsy tube and removed a gastric suction biopsy in which he discovered his own Helicobacter species. He did not think it was important because he had seen similar bacteria in cats. Ito, a Japanese-born American, carried Helicobacter pylori, as did most Americans and Japanese born before 1930. Professor Ito, who is now emeritus Professor of Anatomy at the Harvard Medical School, is also famous for being in the highly decorated all Japanese division of the United States Army, which fought in Europe in 1944. In a last ditch effort, the 442nd-known for its toughness-had been sent to tackle the Nazis. Despite heavy artillery barrages and hidden machine gun nests, the 442nd managed to carve through Nazi lines. But the four-day battle was so deadly that when the 442nd's "I" company finally broke through, only 27 soldiers were left alive out of an initial 200. The 442nd lost a total of a thousand soldiers in rescuing the 175 Texan survivors.
Although others studied spiral bacteria between 1920 and 1979,6 there was reduced interest in the field as the pathologist Edward Palmer stated in 1954 that "infestation is an agonal or post -mortem process" . This implied that the spiral bacteria did not cause disease in life.7
The Acute Infection New York City, were interested in hyperammonemia as a cause of hepatic encephalopathy. Besides the colon, they knew that the gastric mucosa generated ammonia by means of urease. They observed that before therapy with antibiotic, most of the nitrogen present in the gas tric juice was there as ammonium. Subsequently, after antibiotics, most of the nitrogen was present as urea, thus showing that urea breakdown was prevented by antibiotic treatment. 11 Lieber concluded that gastric urease must have been due to bacteria, but his more senior colleagues generally did not believe him. He then repeated the experiment with other antibiotics, and again showed that gastric ammonia production ceased. Lieber and others then suggested that anti biotics such as oral neomycin would be good treat ment for hyperammonemia since they interfered with both gastric and colonic urease activities and did not have systemic toxicity because they were not well absorbed.
Therapy
Treatment of gastric spiral bacteria has been carried out for more than 100 years and several groups used antibiotics to treat ulcers even before H. pylori was discovered. The forerunner antimicrobial, similar in structure to Kobayashi's Arsaminol, was bismuth. In 1900, a suspension of bismuth subsalicylate compound called Bismosal was made by the Norwich Company in Connecticut, USA. This was used for the treatment of infantile cholera. We now know that infantile cholera (spiral organisms present in the stool of infants) was probably a Campylobacter jejuni infection. Campylo bacter is one of many organisms that are killed by bismuth, so Bismosal was probably a very effective therapy. In later years, bismuth subsalicylate, bismuth subcarbonate and bismuth subnitrate were all used as oral treatments for gastric upset and gastric ulcers. These compounds were never studied in proper clinical trials because before 1940, x-ray barium meals and en doscopy were difficult to obtain. In addition, bismuth salts were thought to be antacids, rather than antibac terial agents, so their use in many countries was phased out once more powerful antacids such as magnesium and aluminium hydroxide were available. In Germany, however, where there was a tradition of bismuth treat ment, bismuth compounds remain in many gastric med ications to the present day.
Antibiotic treatment for ulcers was actually pio neered by a Greek physician called John Lykoudis. He became famous between 1960 and 1970 after he treated thousands of patients in a special clinic in Athens. He gave a combination antibiotic therapy that included non-absorbed quinolones. Although he presented his ideas to the drug companies and attempted publication in refereed journals, the concept of a bacterial cause of peptic ulcer was ignored and none of his work was published. 12 In the 1970s, physicians in Spain and China noticed that drugs such as furazolidone and metronidazole seemed have a beneficial effect on patients with ulcers. One interesting statement from the Chinese literature was that the diagnosis of a malignant ulcer could be made using a barium meal in the following manner.13 If the patient was given antibiotics for two weeks, then the swollen and inflamed margin of the benign gastric ulcer would diminish in size, proving that the ulcer was be nign rather than malignant.
So in summary, we can say that before Marshall and Warren made their discovery, it was known that most animals had spiral bacteria in their stomach. These bacteria resembled spirochaetes or spirillae and could even live in the canaliculi of the parietal cells. The bac teria were there in very large numbers so they could not have been contaminants. In conjunction with these bacterial infections, large amounts of gastric urease accumulated which therefore caused significant ammo nia production in infected persons. The enzyme asso ciated with these bacteria, urease, could be shown to be absent from germ-free animals and to disappear when humans were treated with antibiotics. Humans were commonly infected with these spiral bacteria, particu larly persons with a gastric ulcer in whom the infec tion was present in about 80%, but the bacteria could also be seen around the borders of duodenal ulcers. The acute infection associated with these bacteria caused many months of hypochlorhydria and severe neutrophilic gastritis, although many persons seemed to have the infection without symptoms. Finally, the deci sion to use heavy metals and antibiotics to treat gastritis and gastric ulcers could possibly be explained by the inhibitory effect of these compounds on the bacteria. Thus, it gives me great pleasure to acknowledge the initial historic work done by several Japanese inves tigators, defining a tradition of excellence that con tinues to this day.
